Introduction
Caveolin-1 is a 22-kDa membrane protein that forms homo-oligomers and hetero-oligomeric complexes with caveolin-2 and is an essential constituent of the coat structure of caveolae (Monier et al., 1995; Sargiacomo et al., 1995; Scherer et al., 1997) ; (reviewed by Anderson (1998) ). In addition to their structural role, caveolin family members serve as lipid binding adaptor proteins that can interact with speci®c lipids such as cholesterol and glycosphingolipids as well as multiple signaling proteins (Okamoto et al., 1998; Smart et al., 1999) . The Ras ± extracellular signal-regulated kinase (ERK) mitogenic pathway is a speci®c target that is negatively regulated by caveolin-1 both in vitro and in vivo . Similarly, caveolin-1 also inhibits ErbB2 receptor tyrosine kinase activity in vitro and ErbB2-mediated mitogenic signaling in vivo . On the other hand, caveolin-1 mediates integrin-dependent activation of ERK and focal adhesion kinase (FAK) (Wary et al., 1996 (Wary et al., , 1998 Wei et al., 1999) . As a structural component of caveolar membranes caveolin-1 was implicated also in caveolae-dependent functions, including transcytosis, potocytosis and other clathrin-independent endocytic processes (Anderson, 1998) . Additionally, a fairly large body of evidence supports a role for caveolin-1 in cholesterol eux (Fielding and Fielding, 2001) .
Caveolin-1 is expressed in adipose, endothelial, epidermal and epithelial cells but is largely excluded from non-adherent hematopoietic cells (Scherer et al., 1997) . Expression of caveolin-1, however, is induced massively in elicited macrophages (Matveev et al., 1999; Gargalovic and Dory, 2001) . In most cells caveolin-1 is targeted to plasma membrane caveolae. Recently it was demonstrated that caveolin-1 may be targeted also to other organelles in a cell type-speci®c manner (Li et al., 2001b) . Terminal dierentiation is associated with upregulation of caveolin-1 in various cells (Scherer et al., 1994; Galbiati et al., 1998b; Campbell et al., 1999; Mikol et al., 1999) . In contrast, caveolin-1 expression is greatly reduced in most (but not all) oncogenically transformed and human cancer cells examined so far (Sager et al., 1994; Koleske et al., 1995; Engelman et al., 1998b; Lee et al., 1998; Hurlstone et al., 1999; Racine et al., 1999) . Furthermore, antisense inhibition of caveolin-1 expression is sucient to induce a transformed-like phenotype (Galbiati et al., 1998a) . A mutant form of caveolin-1 (P132L) was identi®ed in 16% of primary human breast cancers (Hayashi et al., 2001) . Expression of this mutant P132L-caveolin-1 in NIH-3T3 cells induces morphological transformation, stimulates anchorage-independent growth and promotes extracellular matrix (ECM) invasion, suggesting a dominant negative action (Hayashi et al., 2001) . Conversely, forced expression of wild type caveolin-1 in oncogenetransformed cell lines suppresses anchorage-independent growth . Heterologous expression of caveolin-1 in human T47D breast cancer cells has a similar eect (Lee et al., 1998) . However, it has not been determined whether this is caused by inhibition of cancer cell survival or cell proliferation. These data indicate that caveolin may act as a tumor suppressor protein that imposes an essential cellular requirement for an ECM-derived survival and/or growth signal. Signals derived from the ECM are usually mediated by integrins, heterodimeric membrane proteins that act as receptors for various components of the ECM (Hynes, 1992) . It may therefore be hypothesized that caveolin-1 strongly modulates integrindependent cell functions. Therefore, in the present study we have examined in MCF-7 human breast cancer cells the eect of caveolin-1 expression on anchorage-independent growth, anoikis (i.e. detachment-induced apoptosis) and ECM-induced matrix metalloproteinase (MMP) release and invasiveness.
Results
Caveolar membranes and cholesterol/sphingolipid-rich membrane microdomains (also known as lipid rafts) may be isolated as low-density, detergent-insoluble membranes by¯otation in a sucrose density gradient Brown and London, 2000) . However, recent work has demonstrated an extracaveolar localization of caveolin-1 in certain cells. We have therefore examined the expression and distribution of human caveolin-1, stably transfected into MCF-7 cells, following lysis at 48C and separation of the lysate on a sucrose density gradient. As reported previously (Lavie et al., 1998; Lee et al., 1998; Engelman et al., 1999; Hurlstone et al., 1999) , wild type MCF-7 cells do not detectably express caveolin-1 (Figure 1a ). In contrast, in the stably transfected cells designed MCF-7/Cav1, caveolin-1 is expressed and appears as a doublet in a fraction (fraction 5) that corresponds to the interphase between 30% and 5% sucrose ( Figure 1a) . That fraction usually contains most of the caveolar membranes and lipid raftsassociated proteins. The two caveolin-1-immunoreactive bands correspond to two caveolin-1 isoforms (Cav1a and Cav-1b) that are derived from the same cDNA through alternative translation initiation sites . Further analysis of the gradient fractions revealed that the amount of caveolin-2 in the cells were strongly elevated in the MCF-7/Cav-1 cells with most of the protein located in fraction 5 (Figure 1b) . These data con®rm previous work (Parolini et al., 1999) and are consistent with recent studies indicating that genetic disruption of caveolin-1 destabilizes caveolin-2, resulting in greatly reduced caveolin-2 protein levels (Drab et al., 2001; Razani et al., 2001) .
Forced expression of recombinant caveolin-1 was reported to delay entry into mitosis in human skin ®broblasts (Fielding et al., 1999) and to slow cell proliferation rate in T47D human breast cancer cells (Lee et al., 1998) . There are important dierences between MCF-7 and T47D human breast cancer cells in the regulation of their proliferation (Ludes-Meyers et al., 2001; Schwartz et al., 2001) . Therefore, to examine the eects of caveolin-1 expression in MCF-7 cells we compared the growth curves of wild type MCF-7 cells and stably transfected MCF-7/Cav1 cells. Since endogenous caveolin-1 expression was reported to vary with cell density (Galbiati et al., 1998a) we examined the growth of the cells starting with dierent cell densities. As shown in Figure 2a ± d, MCF-7/Cav1 cells exhibited a slower rate of proliferation regardless of the initial cell density in the cultures. In addition, MCF-7/Cav1 cells proliferation slowed down signi®- Figure 1 Caveolin-1 and caveolin-2 expression and distribution along a sucrose density gradient in MCF-7 and MCF-7/Cav1 cells. MCF-7 and MCF-7/Cav1 cells were lysed in Triton X-100, fractionated by¯otation in a discontinuous sucrose density gradient and the fractions were analysed for caveolin-1 (a) and caveolin-2 (b) immunoreactivity as described under Materials and methods Caveolin-1 inhibits growth, anoikis and invasiveness in breast cancer cells G Fiucci et al cantly after 4 days in culture and approached a plateau phase, while proliferation of the parental MCF-7 cells proceeded almost linearly (Figure 2a ± c) . This phenomenon was less apparent when the cells were seeded at a high initial density (Figure 2d ). Expression of caveolin-1 in oncogenically transformed cells and in T47D cancer cells abrogates anchorage-independent growth Lee et al., 1998) , probably by inhibiting an oncogene-dependent survival and/or growth signal that is normally provided to adherent non-transformed cells by the extracellular matrix via integrins. To test if MCF-7/Cav1 cells require such an essential matrixdependent signal we assessed the capacity for anchorage-independent growth of these caveolin-1-expressing cells by testing their ability to form colonies while suspended in soft agar. The parental MCF-7 cells form numerous large colonies (4220 mm) after 4 weeks of growth in soft agar (Figure 3a) , indicating that like most transformed cells they do not have an essential requirement for a matrix-derived survival/growth signal. In contrast, under the same conditions MCF-7/Cav-1 cells exhibit a reduced capacity for soft agar colon formation, with a lower number of colonies formed and reduced colony size (Figure 3b ). In control experiments in which we have examined empty vectortransfected and p66
Shc -transfected MCF-7 cells, there was no change in soft agar colony formation (data not shown). This suggests that the attenuation of anchorage-independent growth is mediated speci®cally by the expression of caveolin-1 in the transfected cells.
Non-transformed, anchorage-dependent cells undergo anoikis (i.e. detachment-induced apoptosis) when they are deprived of contact with the extracellular matrix, suggesting that they depend on a matrixderived survival signal (Frisch and Francis, 1994; Frisch and Ruoslahti, 1997) . To examine whether the reduced anchorage-independent growth of MCF-7/ Cav-1 cells is caused by a greater sensitivity to anoikis we examined cell survival after detachment and culture in dishes coated with polyhydroxyethylmethacrylate (poly-HEMA), in which adherence of cells to the dishes is prevented (Folkman and Moscona, 1978) . Although MCF-7 cells are anchorage-independent (see above) these cells were found to undergo anoikis as evinced by a *50% decrease in cell survival after 12 h of detachment (Figure 4 ). Further culture of the cells did not increase the proportion of the surviving cells (data not shown). Unexpectedly, despite being more anchorage-dependent than the parental MCF-7 cells, Figure 4 ). These data suggest that the inhibition of anchorage-independent growth eected by caveolin-1 is not due to enhancement of detachment-induced apoptosis (e.g. by inhibition of survival signaling) but, most likely, to inhibition of oncogene-dependent proliferation. In addition, the induction of full resistance to anoikis suggests that caveolin-1 may promote an integrin-independent survival pathway or inhibit apoptotic mechanisms in these cancer cells.
The loss of anchorage-independent growth in MCF-7/Cav1 cells indicates that these cells may have reverted to a less transformed phenotype. It was therefore important to examine whether expression of caveolin-1 aected also another characteristic feature of carcinoma cells, namely, extracellular matrix invasiveness. The ability of MCF-7 and MCF-7/Cav-1 to release MMP-2 and to invade a basement membrane-like layer was tested in a modi®ed Boyden chamber (Reich et al., 1989 (Reich et al., , 1995 . Expression of caveolin-1 in MCF-7/Cav-1 cells attenuates the invasive capacity of the cells by 45% (Figure 5a ). The reduced invasive capacity of MCF-7/Cav-1 cells is correlated with a 40 ± 50% decrease in MMP-2 release from the cells, compared with the parental MCF-7 cells (Figure 5b ). These data strongly suggest that, in addition to abrogation of matrix-independent growth, caveolin-1 inhibits the invasiveness of breast carcinoma cells, most likely by causing decreased matrix metalloprotease release.
The above results indicate that caveolin-1 modulates at least two integrin-dependent functions, namely integrin-dependent survival and integrin-dependent invasiveness. To begin to explore the molecular mechanisms underlying caveolin's actions we examined two pathways of integrin signaling that may be involved in cell survival and proliferation in MCF-7 cells. Initially, we determined whether expression of caveolin-1 aects the integrin expression pro®le. A¯ow cytometric analysis of integrin subunits in MCF-7 and MCF-7/Cav1 cells revealed no signi®cant dierences in the expression pro®le of integrin a and b subunits ( Table 1 ). The analysis suggests that among the major integrins found in the MCF-7 cells are a2b1, a3b1 and a v b1. Integrin a v b5 was also reported to be expressed in these cells (Carriero et al., 1999) . These integrins are receptors for various forms of laminin and for vitronectin (Plow et al., 2000) and they have been implicated in matrix-dependent mitogenic signaling (Giancotti and Ruoslahti, 1999) .
We next examined growth factor and laminindependent activation of two major signaling pathways: Figure 3 Eect of caveolin-1 expression on anchorage-independent growth of MCF-7 and MCF-7/Cav1 cells. MCF-7 cells (a), and MCF-7/Cav-1 cells (b) were assayed for their ability to proliferate and form colonies in soft agar as described under Materials and methods. Representative ®elds were photographed at a 106 magni®cation and typical individual colonies from each culture were photographed at a 306 magni®cation (inset). The results are representative of ®ve independent experiments. Scale bar=300 mm 
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Caveolin-1 inhibits growth, anoikis and invasiveness in breast cancer cells G Fiucci et al the ERK pathway and the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. To analyse receptormediated activation of ERK we tested the eect of Neu dierentiation factor (NDF) in MCF-7 and MCF-7/Cav-1 cells. NDF activates ErbB2 in MCF-7 cells, resulting in stimulation of ERK1/2 activity (Karunagaran et al., 1996) . The expression and activation of ERK1/2 was analysed by utilizing anti-ERK1/2 and anti-active (phospho)-ERK1/2 antibodies (Yung et al., 1997) on total cell lysates of the mammary adenocarcinoma cells. MCF-7 and MCF-7/Cav-1 cells express comparable amounts of ERK1 and ERK2 proteins (Figure 6a ). NDF (50 ng/ml, 5 min) elicits a massive activation of both ERKs in MCF-7 cells, but the activation is somewhat attenuated in the MCF-7/Cav-1 compared with the parental MCF-7 cells (Figure 6a ). Time course experiments that were carried out in these cell lines revealed that the kinetics of ERK activation were similar in the MCF-7 and MCF-7/Cav-1, peaking at 30 min, but the peak activation of ERK1/2 in MCF-7/Cav-1 cells was lower than in the parental MCF-7 cells (Figure 6b ).
Albeit less dramatic, this attenuation is consistent with previously published reports on the inhibitory eect of caveolin-1 on ERK signaling in other cells . ERK1/2 is activated upon adherence of suspended MCF-7 cells to laminin-coated plates (Figure 7 ). Maximal activation was seen 30 min after plating the cells and was progressively reduced at the 1 h and 2 h time points. In contrast, re-attachment of MCF-7/Cav1 cells to the laminin matrix elicited a very weak activation of ERK1/2 (Figure 7 ), indicating that expression of caveolin-1 strongly inhibits integrindependent activation of ERK1/2 in MCF-7 cells. The activation of the PI3K/Akt pathway was implicated in integrin-mediated survival and invasiveness (Khwaja et al., 1997; Shaw et al., 1997) . It was therefore of interest to examine the eect of caveolin-1 expression on this pathway. The activation of Akt was examined using an anti-phospho-Akt mAb. However, our data indicate that plating MCF-7 cells on a laminin matrix fails to activate Akt; similarly, Akt was not activated in MCF-7/Cav1 cells (Figure 7) . 
Discussion
The present study shows that expression of caveolin-1 in breast adenocarcinoma cells leads to a multifaceted modulation of important aspects of the transformed phenotype. The inhibition of anchorage-independent growth induced by caveolin-1 is herein shown, for the ®rst time, to be accompanied with a signi®cant reduction in matrix-dependent release of MMP-2 and impaired invasive potential. In addition, we show that integrin-mediated activation of ERK1/2 is blocked by expression of caveolin-1. Finally, we demonstrate that although it inhibits anchorage-independent growth, caveolin-1 imparts resistance to anoikis in the MCF-7 cells.
Although the inhibitory eect of caveolin-1 on anchorage-independent growth is well documented Galbiati et al., 1998a; Lee et al., 1998; Hayashi et al., 2001) , it has not been determined if this was due to inhibition of cancer cell proliferation or survival. Here we demonstrate that survival of detached MCF-7 cells is not inhibited by expression of caveolin-1; in fact, survival is promoted. Hence, it may be concluded that the inhibition of anchorage-independent growth by caveolin-1 re¯ects an inhibitory eect on a growth factor-or an oncogenedependent proliferation signal, in accordance with recent work demonstrating that caveolin-1 negatively modulates cell proliferation in ®broblasts Razani et al., 2001 ). Although we show here that NDF-induced activation of ERK1/2 is attenuated, the eect is relatively small and therefore is not likely to explain the loss of proliferation under anchorageindependent conditions. However, the cell response to other growth signals has not been examined here. As MCF-7 cells express a wild type p53 gene (Wosikowski et al., 1995; Ogretmen and Safa, 1997) , an alternative explanation is that caveolin-1 eects a block in cell cycle progression via a p53-dependent pathway as recently suggested based on studies in transgenic mice overexpressing caveolin-1 (Galbiati et al., 2001 ). The invasive capacity of cancer cells is a critical determinant of their metastatic potential (Terranova et al., 1986) . The present work provides evidence, for the ®rst time, that expression of caveolin-1 inhibits release of MMP-2 collagenolytic activity upon plating of MCF-7 cells on Matrigel and, consequently, inhibits the invasiveness of these breast adenocarcinoma cells. Whether this change is accompanied by reduced metastasis of MCF-7/Cav1 cells in vivo remains to be determined. Again, the mechanism underlying this oncosuppressive eect is unknown. The eect of caveolin-1 may depend on its inhibitory eect on ErbB2 . Recent studies have strongly implicated the PI3K/Akt pathway in laminininduced, a6b4 integrin-mediated invasiveness (Chao et al., 1996; Shaw et al., 1997) and ErbB2 was shown recently to cooperate with integrin a6b4 in transmitting the PI3K-mediated invasive response (Gambaletta et al., 2000) . However, our results indicate that MCF-7 cells do not express the a6b4 integrin. Consistently, plating these cells on laminin does not activate the PI3K/Akt pathway. Caveolin-1 must therefore in¯u-ence another ECM-dependent pathway to negatively modulate MMP-2 release and invasiveness. We have observed here a major inhibitory eect of caveolin-1 on laminin-induced activation of ERK1/2. This pathway too was recently implicated as a positive regulator of matrix invasiveness (Montesano et al., 1999; Kurata et al., 2000; Welch et al., 2000) . It is thus possible that inhibition by caveolin-1 of ERK1/2 activation induced by adherence onto Matrigel may explain the reduced MMP-2 release and inhibition of matrix invasion we observe in MCF-7/Cav1 cells. The inhibitory eect of caveolin-1 on laminin-induced activation of ERK1/2 seemingly contradict previous studies in which caveolin-1 was shown to couple integrin a subunits to the ERK1/2 pathway through recruitment of Fyn, Shc and Grb2-Sos (Wary et al., 1996 (Wary et al., , 1998 . However, caveolin-1 involved in integrin a subunit signaling was not lipid raft-associated, in contrast with the overexpressed recombinant caveolin-1 in MCF-7 cells that is almost exclusively localized in the rafts (Figure 1) . Hence, overexpressed caveolin-1 may inhibit laminin-induced activation of ERK1/2 by sequestering Fyn and Shc in lipid rafts, preventing them from interaction with aintegrins. It should be noted also that those studies were carried out in non-transformed cells, whereas in the present work we have used highly transformed human breast adenocarcinoma cells.
One of the most surprising results obtained in our study was the eect of caveolin-1 on detachmentinduced apoptosis, i.e. anoikis. Given the greatly reduced capacity for anchorage-independent growth of MCF-7/Cav1 cells it might have been expected that these cells would correspondingly exhibit a greatly enhanced anoikis response. Instead, we have found that expression of caveolin-1 in MCF-7 cells promotes survival (i.e. it inhibits anoikis). Much further work is needed in order to elucidate the molecular mechanism(s) underlying this eect. Anoikis can be circumvented by direct activation of several pathways that in adherent cells are activated by integrins, including the FAK/Src pathway (Frisch et al., 1996; Xu et al., 1996) , the ERK1/2 pathway (Moro et al., 1998) and the PI3K/Akt pathway (Khwaja et al., 1997) . As adhesiondependent activation of ERK1/2 is blocked in caveolinexpressing MCF-7 cells, ERK1/2 is not likely to provide a survival signal for these anoikis-resistant cells. In addition, expression of caveolin-1 in MCF-7 cells does not activate the Akt pathway. An alternative possibility that remains is that expression of caveolin-1 in MCF-7 cells has a positive modulatory eect of the FAK/Src pathway (cf. Wei et al. (1999) ), but direct evidence for that is still lacking. Another possibility is that caveolin-1 expression exerts a negative modulatory eect on the apoptotic machinery involved in anoikis, but conclusive evidence for that too is lacking. There are con¯icting reports about the eects of caveolin-1 on apoptotic signaling, indicating that the action of caveolin may be cell type-and expression leveldependent (Timme et al., 2000; Zundel et al., 2000; Li et al., 2001a; Liu et al., 2001) . Our results, showing that anoikis is inhibited by caveolin-1 expression, are consistent with a negative modulatory eect of caveolin-1 on apoptosis in cancer cells.
In this context it is interesting to note that some multidrug resistant (MDR) cancer cells express high levels of caveolin-1 and caveolin-2, and exhibit a high surface density of caveolae, when compared with the parental, drug-sensitive cells (Lavie and Liscovitch, 1997; Lavie et al., 1998; Yang et al., 1998; Bender et al., 2000) . The functional signi®cance of these ®ndings and their relation to the MDR phenotype are largely unknown. We have recently hypothesized that caveolin-mediated cholesterol eux pathways may play a role in facilitating drug transport to plasma membrane drug eux ATPases (Liscovitch and Lavie, 2000) . Alternatively, caveolin-1 may be positively selected because it has anti-apoptotic properties when highly expressed in cancer cells, a possibility that is supported indirectly by the present anoikis data.
While the possible role(s) played by caveolin and caveolae in mediating the MDR phenotype per se remain to be elucidated, our results suggest that high caveolin-1 expression may have a strong impact on mitogenic signaling and regulation of the transformed phenotype in MDR cells. Previous studies have indicated that multidrug resistance is associated with reduced tumorigenicity in vivo in most studies where this has been examined. The transformed cell lines in which these observations were made include multidrug resistant ovarian carcinoma cells (Benard et al., 1989) , lung carcinoma cells (Mattern et al., 1990) , v-Srctransformed ®broblasts (Shtil et al., 1994) , spontaneously transformed hamster lung cells (Biedler and Spengler, 1994) and human osteosarcoma cells (Scotlandi et al., 1996) . In the latter case, the expression of P-glycoprotein itself contributes to the loss of anchorage-independent growth in vitro and the inability of the multidrug resistant osteosarcoma cells to grow and metastasize in vivo (Scotlandi et al., 1999) . The present results obtained with caveolin-1-trans-fected MCF-7 cells indicate that expression of caveolin-1 inhibits anchorage-independent growth and matrix invasiveness in human cancer cells. The overexpression of both caveolin-1 and P-glycoprotein, probably explains the complete loss of anchorage-independent growth and reduced metastatic potential observed in many MDR cells. Understanding the biochemical changes induced by caveolin-1 in these cells may therefore help delineate novel approaches for suppressing growth of MDR cancer cells.
Materials and methods
Materials
Unless otherwise stated, all reagents were from Sigma. Protein assays were performed using a modi®ed Lowry procedure with a commercially available kit (Bio-Rad).
Cell culture and generation of stably-transfected MCF-7/Cav1 cells
Human breast adenocarcinoma MCF-7 cells were kindly provided by Dr Merrill E Goldsmith (National Cancer Institute, Bethesda, MD, USA). MCF-7 and cell lines derived thereof were grown according to published procedures (Fairchild et al., 1987) . In brief, cells were cultured in monolayer at 378C in a humidi®ed atmosphere containing 5% CO 2 in RPMI medium supplemented with 10% (v/v) heat-inactivated fetal calf serum, penicillin and streptomycin (1000 U/ml each) and glutamine (20 mM) (all from Biological Industries). To generate caveolin-1-transfected MCF-7 cells we utilized a full length human lung caveolin-1 cDNA, kindly provided by Dr Albert Taraboulos (Hebrew University). This cDNA was subcloned into a pJB20 vector using EcoRI sites. Ten mg of DNA were transfected into 6610 6 cells in a 100-mm dish using LipofectAMINE (Life Technologies) according to the manufacturer's instructions. The selection for transfected cells was carried out in a medium containing 400 mg/ml G418 (Calbiochem) for at least 4 weeks before the experiments. The stable transfectants were pooled and used as a population designated MCF-7/Cav-1.
Isolation of caveolin-rich membrane domains in sucrose density gradient
Low density Triton X-100-insoluble membrane domains were puri®ed from cultured cells essentially as described . Brie¯y, cell monolayers (two con¯uent 150-mm dishes, *3610 7 cells) were scraped in 1 ml of ice-cold lysis buer containing 25 mM MES, pH 6.5, 0.15 M NaCl, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 1% Triton X-100. After homogenization, cell extracts were adjusted to 40% sucrose by addition of 1 ml of the above buer (minus Triton X-100) containing 80% sucrose, and placed at the bottom of a 12 ml ultracentrifuge tube. A discontinuous gradient was formed above the lysate by adding 4 ml each of 30 and 5% sucrose solutions, and the tubes were centrifuged in an SW-41 rotor at 190 000 g (39 000 r.p.m.) for 16 ± 20 h at 48C. Fractions (0.9 ml) were collected beginning at the top of the gradient. The pellet was resuspended in 0.9 ml of MES-NaCl buer and was designated fraction 12. Aliquots taken from each of the sucrose density gradient fractions were resolved by SDS ± PAGE. Proteins were transferred to nitrocellulose membranes and blocked by incubation with 5% skim milk (w/v) in phosphate-buered saline containing 0.1% Triton X-100 (T-PBS) for 1 h. Immunoblot analysis of caveolin was carried out with monoclonal antibodies to caveolin-1 (clone 2297, Transduction Laboratories) and caveolin-2 (clone 65, Transduction Laboratories). The blots were then washed extensively and incubated with horseradish peroxidase-linked goat anti-mouse IgG. Bands were visualized by enhanced chemiluminescence using a commercially available kit (Amersham Pharmacia Biotech).
Activation of ERK1/2 and of Akt
Forty-eight hours prior to immunoblot analysis experiments for ERK, the cells were cultured in supplemented RPMI medium lacking serum. The activation of ErbB2 receptor was done by incubating the cells for the indicated time with 50 ng/ml NDF, kindly provided by Prof. Yosef Yarden (Weizmann Institute). For analysis of total cell lysates, *10610 6 cells were scraped with a rubber policeman in 0.5 ml of lysis buer containing 25 mM MES, pH 6.5, 0.15 M NaCl, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 2 mM Na 3 VO 4 , 1% Triton X-100. Samples containing equal amount of proteins were subjected to 10% SDS ± PAGE, transferred to nitrocellulose, blocked for 1 h with 5% (w/v) skimmed milk in phosphate-buered saline containing 0.1% Triton X-100, and probed with antiactive ERK1/2 and anti-ERK1/2 antibodies (Sigma). The blots were then washed extensively and incubated with horseradish peroxidase-linked goat anti-rabbit or goat antimouse IgG. Speci®c binding was detected by enhanced chemiluminescence using a commercially available kit (Amersham Pharmacia Biotech). Densitometry quanti®cation of ®lms was performed using the Quantity One v.3 software. To test laminin-induced activation of ERK1/2 and Akt, MCF-7 and MCF-7/cav-1 were starved for 48 h, detached with 3 mM EDTA and either left in suspension or plated on dishes coated with laminin (Boehringer Mannheim) for dierent times (0.5, 1 and 2 h). The attached cells were then lysed in a MES buer containing 1% Triton and the above-listed supplements and subjected to immunoblot analysis.
MTT cell proliferation/viability assay
To determine cell proliferation rates, MCF-7 and MCF-7/ Cav1 cells were plated in 96-well plates at the indicated density in 0.1 ml RPMI containing 5% fetal calf serum, and cultured at 378C for up to 6 days. Cell growth was then assessed using the conversion of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to a formazan product according to Hansen et al., (1989) . Brie¯y, the MTT reagent (diluted from a 5 mg/ml solution in PBS) was added to all the wells at a ®nal concentration of 0.6 mg/ml and the cells were further incubated for 2 or 3 h at 378C. The reaction was terminated by adding 100 ml/well of an extraction solution consisting of 20% (w/v) sodium dodecyl sulfate (SDS) in 50% aqueous dimethyl formamide solution, pH 4.8. The plates were left overnight in the dark at room temperature, following which the absorbance was read at 570-nm using an ELISA plate reader. Three to six wells were treated with 1% SDS (®nal concentration) for 5 min prior to adding the MTT reagent, and the average absorbance values obtained from these wells served as blank and was subtracted from all other results. Data points represent the mean+s.d. of a quadruplicate determination from a representative experiment that was repeated at least twice.
Colony formation in soft agar
Anchorage-independent growth was determined by assaying colony formation in soft agar as described by Koleske et al., (1995) , with minor modi®cations. Brie¯y, single-cell suspensions of MCF-7 and MCF-7/Cav-1 cells were prepared from monolayer cultures by treatment with a mixture of 300 u/ml trypsin, 20 u/ml elastase, and 1.5 mM EDTA. (Note: The presence of elastase was essential for complete dissociation of MCF-7 cells into a single cell suspension.) Cells were suspended in DMEM containing 10% FCS and 0.33% Seaplaque low melting temperature agarose (FMC; Cat. # 50101), and 2 ml containing 2610 4 cells were plated in a 35mm dish over a 3 ml layer of solidi®ed DMEM/10% FCS/ 0.6% agarose. The cells were fed every 3 ± 4 days by adding 200 ml of DMEM/10% FCS. Colonies were photographed at 106 and 306 magni®cation after 4 weeks.
Anoikis assay
To prevent cell adhesion, plastic bacteriological Petri dishes were coated with poly-HEMA according to a previously published procedure (Folkman and Moscona, 1978; Xu et al., 2000) . Brie¯y, a 12% solution of poly-HEMA (Sigma) in 95% ethanol was mixed overnight, clari®ed by centrifugation at 2500 r.p.m. and diluted 1 : 10 in 95% ethanol. Dishes were coated with the diluted poly-HEMA solution (4-ml per 100-mm dish) and the ethanol solvent was left to evaporate overnight in a laminar¯ow hood at room temperature. Cells were then seeded at a concentration of 3610 6 cells/dish and cultured in RPMI medium supplemented with 5% (v/v) fetal calf serum for 0 ± 12 h. At the end of the indicated culture period the cells were collected and 150 ml aliquots were transferred to 96-well plates. Cell survival was determined by conversion of MTT as described above. Some wells were treated with 1% SDS (®nal concentration) for 5 min prior to adding the MTT reagent, and the average absorbance values obtained from these wells served as a blank which was subtracted from all other results. Data points represent the means+s.d. of seven replicates per time point from 2 ± 4 independent experiments.
Matrix metalloprotease release and matrix invasion assays
Sub-con¯uent cells were incubated for 24 h in serum-free DMEM and the resultant supernatant was analysed for collagenolytic activity by zymography on gelatin impregnated (1 mg/ml; Difco), SDS 8% polyacrylamide gels as described (Ballin et al., 1988; Reich et al., 1995) . Brie¯y, culture media samples were separated on the substrate-impregnated gels under non-reducing conditions, followed by 30 min incubation in 2.5% Triton X-100. The gels were then incubated for 16 h at 378C in 50 mM Tris, 0.2 M NaCl, 5 mM CaCl 2 , 0.02% Brij-35 (w/v) at pH 7.6. At the end of the incubation period the cells were stained with 0.5% (w/v) Coomassie G-250 (BioRad, Richmond, CA, USA) in methanol/acetic acid/H 2 O (30 : 10 : 60). The intensity of the various bands was determined on a computerized densitometer (Molecular Dynamics).
Basement membrane invasion was determined in a modi®ed Boyden chamber as described (Reich et al., 1989) . Brie¯y, Matrigel (25 mg) was dried on a polycarbonated ®lter (PVP Free, Nucleopore). Fibroblast conditioned medium (obtained from con¯uent NIH3T3 cells cultured in serum-free DMEM) was used as the chemoattractant. Cells were harvested by brief exposure to 1 mM EDTA, washed with DMEM containing 0.1% bovine serum albumin and added (2610 5 cells/0.2 ml) to the Boyden chamber. The chambers were incubated in a humidi®ed incubator at 378C in an atmosphere of 5% CO 2 /95% air for 6 h. The cells which traversed the Matrigel layer and attached to the lower surface of the ®lter were stained with Di-Quick (American Scienti®c Products) and counted.
Flow cytometry analysis
FACS analysis was performed using a FACS Calibur instrument (Becton Dickinson) and the Cell-Quest software. Cells were washed in PBS and non speci®c binding of antibodies to FcR was blocked by preincubating cells with an anti CD16/CD32 mAb (PharMingen). Cells were then washed and incubated with 10 mg/ml of integrin-speci®c Ab for 1 h on ice, then washed twice and incubated with FITCconjugated secondary Ab for 1 h on ice. Cells were washed twice, resuspended in 200 ml of 4% PFA and analysed by FACS. The antibodies used were: b1 (CD29) from Immunotech; b4 and a1 from the MSKCC Monoclonal Facility; a2 (PIE6), a3 (PIB5), a5 (PID6) from GIBCO; and a6 (CD49F) from PharMingen. FITC-conjugated secondary antibodies were from Molecular Probes.
